The information within this section of the website is intended for patients in the United Kingdom who have been prescribed Inbrija® (levodopa inhalation powder).
Inbrija® is a medicine used by inhalation for treating the worsening of your symptoms during the ‘off periods’ of Parkinson’s disease.

Inbrija® (levodopa inhalation powder)

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme online: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

By reporting side effects you can help provide more information on the safety of this medicine.

Meet Peter

“Hi, I’m Peter. I’m 55 years old and have been living with Parkinson’s Disease for five years.

I work part-time as a shop assistant and in my free time I enjoy playing the piano in a little music group with my friends, and I enjoy spending time with my grandchildren.

I sometimes get OFF episodes when my Parkinson’s medication does not control my condition well enough.

My doctor has prescribed Inbrija® to help with those OFF episodes.

Be sure to read the documents on this site, especially the Patient Information Leaflet”

Note: Peter is a fictional person.

Like all medicines, this medicine can cause side effects, although not everybody gets them. Please make sure to read the Patient Information Leaflet (PIL) available via the following link: here, for full information on possible side effects, as well as warnings and precautions.

Get urgent medical help if you have an allergic oedema with symptoms including hives (nettle rash), itching, rash, swelling of your face, lips, tongue, or throat. This may cause difficulties in breathing or swallowing.

Get urgent medical help if your muscles get very rigid or jerk violently, you get tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood pressure. These can be symptoms of neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines used to treat disorders of the central nervous system) or rhabdomyolisis (a rare severe muscle disorder).

Get urgent medical help if you have bleeding in your stomach or intestines which may be seen as blood in your faeces or darkened faeces.

The following list includes very common (may affect more than 1 in 10 people) and common (may affect up to 1 in 10 people) side effects that may happen with this medicine.

Very common (may affect more than 1 in 10 people):

  • cough

Common (may affect up to 1 in 10 people):

  • new or increased abnormal body movements (dyskinesia);
  • infections of nose, sinuses, throat or lungs;
  • change in colour of your mucus;
  • discoloured (i.e. not clear) nasal mucus;
  • irritation in throat or itchy throat;
  • feeling sick (nausea); vomiting;
  • being prone to falls.

For a full list of warnings & precautions, side effects and safety information, please ensure to read the Patient Information Leaflet (PIL) in the Inbrija box, or available here.

This website contains information about INBRIJA® (levodopa inhalation powder)

I am a member of
the public

M-INB-UK-0047
Date of preparation: December 2025